Pfizer at 10-year support: Is it a massive buy opportunity?

Key PointsPfizer's stock has experienced a significant decline of over 50% from its pandemic peak.Despite challenges, Pfizer's latest earnings report revealed resilience, topping estimates with an unexpected fourth-quarter profit.Analysts forecast an impressive upside for Pfizer, with a consensus price target of $36.93, and the stock boasts an attractive dividend yield of 6.11%.5 stocks we like better than PfizerFor shareholders of the multinational biotech giant Pfizer Inc. NYSE: PFE, it might feel like th ...